|
|
||||||||
J Thorac Cardiovasc Surg 2008;136:1390
© 2008 The American Association for Thoracic Surgery
Letter to the Editor |
Hadassah–Hebrew University Medical Center, Department of Cardiothoracic Surgery, Hadassah, Jerusalem, Israel
| The first 20% of the full text of this article appears below. |
To the Editor:
I read with great interest the article by Guenter Weigel and colleagues.1
I want to commend the authors for their great effort to understand the cascade of molecular events leading to neovascularization in coronary sinus interventions. However, I would like to add some comments.
The term "Beck procedure" alone is a nonspecific term inasmuch as Dr Claude Beck has described two types of coronary sinus interventions.2-4
The first one, the Beck I procedure, consisted of narrowing
This article has been cited by other articles:
![]() |
W. Mohl, S. Mina, D. Milasinovic, H. Kasahara, and S. Wei The legacy of coronary sinus interventions: Endogenous cardioprotection and regeneration beyond stem cell research. J. Thorac. Cardiovasc. Surg., November 1, 2008; 136(5): 1131 - 1135. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |